Tech Company Financing Transactions
EnginZyme Funding Round
EnginZyme closed a $7.6 million funding round on 9/24/2026. Backers included Almi Invest GreenTech, Industrifonden and Navigare Ventures.
Transaction Overview
Company Name
Announced On
9/24/2026
Transaction Type
Venture Equity
Amount
$7,600,000
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds to accelerate its shift from R&D to a commercially driven strategy and deliver biomanufacturing solutions for the personal care, food, and pharmaceutical industries.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Tomtebodavägen 6
Solna, 171 65
SE
Solna, 171 65
SE
Phone
Website
Email Address
Overview
EnginZyme is recognised as a Technology Pioneer by World Economic Forum and backed by Sofinnova Partners, Industrifonden and SEB Greentech VC. Our ambition is to play a key role in tackling climate change, by enabling green chemistry for every industry. We do this by creating the most general and efficient technology platform for chemical production that the world has ever seen. That's a big claim, but we can stand behind it. By bio-upgrading the chemical industry with our cell-free biomanufacturing platform, we can produce the products that modern society relies on in a truly sustainable way. The technology platform utilises nature's catalysts, enzymes, by combining the power of biology with the efficiency of the chemical industry in a best-of-both-worlds solution.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 9/24/2026: BigHat Biosciences venture capital transaction
Next: 9/24/2026: Elroy Air venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record all VC transactions involving tech companies. All VC database entries reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








